Abbott Laboratories agreed to pay at least $1.3 billion to settle claims by the U.S. government and 24 states alleging the company illegally marketed its Depakote epilepsy drug, people familiar with the accords said.
Swiss banks will likely settle a sweeping U.S. probe of offshore tax evasion by paying billions of dollars and handing over names of thousands of Americans who have secret accounts, Bloomberg News’ David Voreacos, Klaus Wille and Giles Broom report.
Johnson & Johnson, the world’s biggest maker of health-care products, may sell its $2.2 billion diagnostics unit for blood and cholesterol tests as the company focuses on genetic screening to complement its drug pipeline.
Impax Laboratories Inc. said it settled patent litigation with Abbott Laboratories and its Fournier Laboratories Ireland Ltd. unit, permitting Impax to sell a generic version of the cholesterol drug TriLipix as early as 2013.
Facebook Inc. and its co-founder Mark Zuckerberg asked a court to order Paul Ceglia, the New York man who claims half of Zuckerberg’s holdings, to turn over the original contract and e-mails on which he bases his suit, saying the steps are needed to short-circuit a fraud on the court.